已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Concomitant Use of Diosmin/Hesperidin and Oral Rivaroxaban Increases Deep Vein Recanalization and Reduces the Incidence of Post-Thrombotic Syndrome in Patients with Proximal Deep Vein Thrombosis

医学 血栓后综合征 地奥司明 血栓形成 外科 深静脉 随机对照试验 胃肠病学 内科学 相伴的 拜瑞妥 橙皮苷 病理 替代医学 华法林 心房颤动
作者
Kirill Lobastov,Iliya Schastlivtsev,Victor Barinov
出处
期刊:Blood [Elsevier BV]
卷期号:132 (Supplement 1): 986-986
标识
DOI:10.1182/blood-2018-99-110084
摘要

Abstract Aim: To assess the impact of long-term Diosmin/Hesperidin use in the treatment of proximal deep vein thrombosis (DVT). Methods: This study was a pilot randomized open-label study with blinded outcome assessor - enrolled patients with their first episodes of popliteal-femoral DVT confirmed by duplex ultrasound (DUS). All participants were randomized into two groups: 1.) control that received a standard treatment with oral Rivaroxaban, and 2.) experimental that required additional treatment with Diosmin/Hesperidin 450/50 mg twice a day. Both drugs were used for six months. Patients were followed-up for the whole treatment period with series DUS every two months in order to evaluate the degree of recanalization by popliteal (PV), superficial femoral (SFV), and common femoral (CFV) veins' compressibility. Thrombi extension was assessed by modified Marder score. At the end of the follow-up period, patients were assessed with Villalta and venous clinical severity scores. Post-thrombotic syndrome (PTS) was diagnosed in those who had ≥5 Villalta score. Results: Sixty patients were randomized to the control and experimental groups (n=30 in each group). There were 40 men and 20 women with mean age of 56.3±13.4. Clinically unprovoked DVT was recognized in 65% of cases and left side localization in 45%. The median of Marder baseline scores were 15.0±4.8 and 11.1±4.3 in the experimental and control groups, respectively (p=0.002). After six months of treatment, the Marder score decreased to 0.8±1.6 and 2.8±3.5 in the main control groups, respectively (p=0.006). The generalized linear model repeated measures found a greater reduction in the Marder score (р <0.0001) and increased speed of recanalization on SFV (р <0.0001) with a non-significant tendency in the CFV (p=0.130) and PV (p=0.204) in the experimental group compared to the control one. Full recanalization of the PV at six months was observed in 24 patients (80%), who had received Diosmin/Hesperidin, and only in 17 persons (57%) of the control group (p=0.047). The median of Villalta score in the group treated with Diosmin/Hesperidin was significantly lower compared to the control one (2.9±2.7 versus 5.8±3.0 [p <0.0001]). The same difference was found for VCSS score (2.3±1.9 versus 4.9±1.9 [p <0001]). According to the Villalta score, PTS was recognized in six patients (20%) and 17 patients (57%) in the experimental and control groups, respectively (p=0.004). Conclusion: Long-term treatment with Diosmin/Hesperidin can increase the speed of deep vein recanalization and reduce the incidence of PTS diagnosed at six months in patients with proximal DVT treated with oral rivaroxaban. Disclosures Lobastov: Bayer: Honoraria, Speakers Bureau; Servier: Honoraria, Speakers Bureau. Schastlivtsev:Bayer: Honoraria, Speakers Bureau; Servier: Honoraria, Speakers Bureau. Barinov:Bayer: Honoraria, Speakers Bureau; Servier: Honoraria, Speakers Bureau.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
劉浏琉发布了新的文献求助10
刚刚
lingo完成签到 ,获得积分10
1秒前
科研通AI6.4的应助被Elaina采纳,获得10
2秒前
方剂小于完成签到,获得积分10
3秒前
lynn完成签到,获得积分10
3秒前
乐乐的应助被MO采纳,获得10
3秒前
tjnksy完成签到,获得积分0
4秒前
高贵嘉懿完成签到,获得积分10
4秒前
无花果的应助被拉长的人雄采纳,获得10
5秒前
CodeCraft的应助被Jason采纳,获得10
6秒前
方剂小于发布了新的文献求助10
6秒前
魔幻的松思完成签到,获得积分10
7秒前
欣慰的海发布了新的文献求助10
8秒前
学霸业的应助被小学生686采纳,获得10
8秒前
飘逸的听露完成签到 ,获得积分10
9秒前
方法完成签到,获得积分10
10秒前
lyra完成签到,获得积分10
11秒前
Nole的应助被lhd采纳,获得10
12秒前
五仁月饼完成签到,获得积分20
13秒前
WizBLue完成签到,获得积分10
13秒前
零点完成签到 ,获得积分10
13秒前
红岚幽客完成签到,获得积分10
13秒前
zys发布了新的文献求助10
14秒前
也无风雨也无晴完成签到,获得积分10
16秒前
毒药完成签到 ,获得积分10
16秒前
19秒前
Amelk完成签到,获得积分10
20秒前
拉长的人雄完成签到,获得积分20
22秒前
23秒前
劉浏琉发布了新的文献求助10
24秒前
花海发布了新的文献求助10
24秒前
星辰大海的应助被明理的谷芹采纳,获得30
24秒前
27秒前
27秒前
30秒前
晴空万里发布了新的文献求助10
30秒前
Lee发布了新的文献求助10
30秒前
Xenomorph完成签到,获得积分10
30秒前
QQp完成签到,获得积分10
31秒前
dtt完成签到,获得积分10
32秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8172758
求助须知:如何正确求助?哪些是违规求助? 9565356
关于积分的说明 21779652
捐赠科研通 7764670
什么是DOI,文献DOI怎么找? 3431480
关于科研通互助平台的介绍 2555430
邀请新用户注册赠送积分活动 2476460